6家非上市寿险总投资收益率超3% | | 2025年非上市寿险公司半年度投资收益率(前十) | | | --- | --- | --- | | 序号 | 公司名称 | 累计投资收益率(%) | | ] | 君龙人寿保险有限公司 | 4. 67 | | 2 | 北京人寿保险股份有限公司 | 3.65 | | 3 | 利安人寿保险股份有限公司 | 3.22 | | 4 | 幸福人寿保险股份有限公司 | 3.08 | | 5 | 国民养老保险股份有限公司 | 3.01 | | 6 | 财信吉祥人寿保险股份有限公司 | 3.00 | | 7 | 小康人寿保险有限责任公司 | 2. 96 | | 8 | 弘康人寿保险股份有限公司 | 2. 95 | | 9 | 华贵人寿保险股份有限公司 | 2. 94 | | 10 | 光大永明人寿保险有限公司 | 2. 89 | | 数据来源:企业预警通 | | 制表:21世纪经济报道 | 从上半年投资收益率来看，59家非上市寿险公司中有6家超过3%。其中，君龙人寿保险有限公司以4.67%的收益率位居榜首；北京人寿保险股份有限 公司紧随其后，收益率为3.65%；利安人寿保险股份有限公 ...

险企发行资本补充债和永续债的另一个特征是，发行债券的票面利率逐年下行。今年以来，险企发行债 券的票面利率范围在2.18%—2.80%之间，与往年相比逐步走低。 本报记者 冷翠华 见习记者 杨笑寒 3月19日，太平人寿保险有限公司（以下简称"太平人寿"）成功发行规模为90亿元的无固定期限资本债 券（也称为"永续债"）。 今年以来，险企发债步履不停。数据显示，截至3月20日，险企发行资本补充债和永续债的规模合计达 366亿元。 受访专家表示，险企加速发行债券，与偿付能力要求提高、市场利率环境走低、扩展业务需求等因素有 关，此外，部分险企"赎旧发新"也推高了资本补充债和永续债的发行规模。未来，预计险企资本补充需 求将维持在高位，会有更多险企尝试新型资本补充工具。 "赎旧发新"降成本 3月19日，太平人寿发行90亿元永续债，票面利率为2.40%。太平人寿公告显示，本期债券募集资金将 依据适用法律和监管部门的批准用于补充发行人核心二级资本，提高发行人偿付能力，为发行人业务的 良性发展创造条件，支持业务持续稳健发展。 Wind数据显示，截至3月20日，今年共有8家险企发行资本补充债和永续债，规模合计达366亿元。相较 而 ...

Core Insights - The speed of capital replenishment among insurance companies has significantly increased recently, with major issuances of perpetual bonds [1][2] - The total issuance of perpetual bonds by insurance companies this year has reached 457 billion yuan, surpassing the total of 359 billion yuan for the entire previous year [2] Group 1: Recent Issuances - Taiping Life successfully issued 9 billion yuan of perpetual bonds with a coupon rate of 2.40% [1] - Eight insurance companies, including Taiping Life, Ping An Life, and Taikang Life, have issued capital replenishment bonds and perpetual bonds totaling 36.6 billion yuan [1] - Among these, five companies issued perpetual bonds, amounting to a total of 32.7 billion yuan [1] Group 2: Market Trends - The issuance of perpetual bonds has been driven by higher capital adequacy requirements under the second phase of the solvency regime, prompting companies to replenish capital [2] - Current market interest rates are relatively low, allowing insurance companies to finance at a lower cost [2] - The coupon rates for perpetual bonds issued in 2023 range from 2.20% to 2.48%, while those for 2024 are between 2.20% and 2.50% [2]

Group 1 - The core viewpoint of the articles highlights the increasing capital needs of insurance companies in China, driven by stricter regulatory requirements and the need to support business growth [1][2][3] - As of June 20, 2023, the Beijing Regulatory Bureau approved capital increases for Zhongyou Life and China United Life, with Zhongyou Life's capital rising from 28.663 billion to 32.643 billion yuan and China United Life's from 2.9 billion to 4.1 billion yuan [1] - In 2023, insurance companies have collectively raised 69.213 billion yuan through capital increases and bond issuance, marking a 95% year-on-year increase [1] Group 2 - At least six insurance companies have been approved for capital increases this year, totaling 8.853 billion yuan, including Ping An Life and Guolian Life [1] - Twelve insurance companies have issued capital supplement bonds or perpetual bonds, with a total issuance scale of 60.36 billion yuan [1] - The second phase of the solvency regulatory framework has led to a decline in solvency adequacy ratios for many insurance companies, necessitating external capital supplementation through shareholder investments and bond issuance [2] Group 3 - New capital supplementation methods are emerging, allowing insurance companies to diversify their capital-raising strategies and enhance flexibility [3] - Regulatory adjustments, such as extending the transition period for solvency regulations and reducing risk factors for stock investments, aim to optimize capital structures for insurance companies [3] - Insurance companies, especially smaller ones, are encouraged to leverage regulatory transition policies and seek external funding while adjusting their business structures to reduce capital consumption [3]

Core Viewpoint - The article discusses the implementation of the second phase of the solvency regulatory framework in China's insurance industry, focusing on the concept of future policy surplus as a key indicator of a company's future profitability [1][2]. Group 1: Future Policy Surplus - The future policy surplus is introduced under the second phase of solvency regulations and is crucial for assessing a company's future profitability [1]. - The future policy surplus is defined as the difference between accounting reserves and solvency reserves, adjusted for potential tax provisions and cash value guarantees [2]. - As of 2024, the future policy surplus for 66 insurance companies is projected to be 2.26 trillion, accounting for 8.8% of total assets, a decrease of approximately 150 billion from the end of 2022 [14]. Group 2: Impact of Accounting Standards - Starting in 2023, insurance companies began implementing the new accounting standard IFRS 17, which affects how insurance reserves are reported [3]. - The article highlights the importance of consistency in reporting deferred tax liabilities (DTL) and actual capital across different accounting standards [7][8]. - Companies that do not maintain consistency in their reporting may face challenges in validating their solvency reports [9]. Group 3: Analysis of Companies - The article provides a detailed analysis of various insurance companies, noting that the future policy surplus varies significantly among them, with some companies like AIA Life exceeding 15% of total assets [14]. - The article identifies that companies with a high proportion of participating insurance products tend to have lower future policy surplus compared to traditional insurance products [16]. - The future policy surplus for major players like China Life and Ping An has shown a noticeable decline, attributed to their historical focus on participating insurance products [15]. Group 4: Factors Influencing Future Policy Surplus - The decline in future policy surplus can be attributed to several factors, including a high proportion of participating insurance, adjustments in risk premiums, and changes in actuarial assumptions [19]. - Conversely, an increase in future policy surplus may result from a lower proportion of participating insurance and the successful generation of new business [19][22]. - The article emphasizes that the future policy surplus is a critical indicator but does not fully reflect a company's overall asset-liability management (ALM) status [16].

Core Viewpoint - Insurance companies have accelerated their capital replenishment efforts since 2025, with a total issuance of perpetual bonds and capital replenishment bonds reaching 49.6 billion yuan, alongside approved capital increase plans totaling 3.673 billion yuan, indicating a significant push to enhance solvency amid regulatory changes and market pressures [1][3][4]. Group 1: Capital Replenishment Trends - As of May 18, 2025, insurance companies have collectively achieved over 53 billion yuan in capital replenishment, with more than 10 billion yuan in additional capital increases in progress [1][2]. - The issuance of perpetual bonds has become a key method for insurance companies to supplement core tier 2 capital, with 11 companies issuing a total of 49.6 billion yuan in 2025, significantly surpassing the 14 billion yuan issued in the same period of 2024 [3][4]. - The average coupon rate for perpetual bonds in 2025 ranges from 2.18% to 2.75%, reflecting a decrease from previous years, making it an attractive option for insurers to optimize their capital structure [4][5]. Group 2: Regulatory Environment and Challenges - The implementation of the "Solvency II Phase II" project has led to stricter recognition of core capital, increasing the pressure on insurers to enhance their solvency ratios [1][12]. - Regulatory requirements stipulate that the balance of perpetual bonds must not exceed 30% of core capital, and capital replenishment bonds must not exceed 100% of net assets, limiting the issuance primarily to larger insurance firms [5][6]. - The overall solvency ratio for the insurance sector stood at 204.5% as of the end of Q1 2025, with property and life insurance companies showing varying levels of solvency [8][9]. Group 3: Company-Specific Developments - Companies like Guolian Life and Huagui Life have been particularly active in capital increases, with Guolian Life's solvency ratio dropping to 103.97% by Q1 2025, prompting a 3 billion yuan capital increase to bolster its solvency [9][10]. - Huagui Life, backed by the Moutai Group, has also reported declining solvency ratios, indicating a need for capital infusion to maintain operational stability [9][10]. - Conversely, companies like Dinghe Property Insurance, with solvency ratios exceeding 500%, are pursuing capital increases to support expansion into new business areas, despite their strong capital position [10][11].

经营状况持续承压，财务表现呈现多重隐忧，内部治理混乱，多项投资决策流程形同虚设，面对多重治理挑战，瑞泰 人寿能否走出困境？ 瑞泰人寿保险有限公司（以下简称：瑞泰人寿）作为一家成立于2004年的中外合资寿险公司，近年来经营状况持续承 压，财务表现呈现多重隐忧。根据披露的财务数据显示，2024年瑞泰人寿亏损达1.88亿元，同比增亏17.35%。已连续 两年净亏损，2023年净利润亏损1.42亿元。 尽管该公司总资产规模增长至125.25亿元，但负债总额同步攀升至116.81亿元，而所有者权益仅8.44亿元，资本实力薄 弱。这家成立近20年的中外合资寿险公司，正深陷"保费难增、投资难赚、成本难降"的恶性循环，叠加屡次违规暴露 的公司治理沉疴，其生存危机已从财务亏损蔓延至系统性风险层面。 针对该公司经营业绩、内部治理、风控以及人事管理等问题，发现网向瑞泰人寿发送采访调研函，截至发稿前，瑞泰 人寿未就相关问题给予合理解释。 保费增长动能不足与业务结构失衡 （主要经营指标：瑞泰人寿2024年第四季度偿付能力报告） 而财务数据揭示了该公司经营效率亟待提升，2024年总营业收入16.75亿元中，已赚保费12.15亿元，同比增 ...

Core Viewpoint - Perpetual bonds are becoming a new "capital ammunition depot" for leading insurance companies, with issuance reaching a historical peak of 23.7 billion yuan at the beginning of 2025 [1][3]. Group 1: Perpetual Bond Issuance - The issuance of perpetual bonds has surged, with insurance companies issuing a total of 35.77 billion yuan in 2023 and 35.9 billion yuan in 2024, while 23.7 billion yuan has already been issued in early 2025 [3]. - The issuance of perpetual bonds is primarily concentrated among AAA-rated leading insurance companies, as regulatory guidelines restrict the issuance to a maximum of 30% of core capital [4][5]. - The issuance of perpetual bonds serves as a low-cost financing method for insurance companies, allowing them to address capital pressures and optimize their capital structure [3][6]. Group 2: Driving Factors - The surge in perpetual bond issuance is driven by the need for effective capital supplementation amid tightening insurance regulations and the pressure on core solvency ratios [6]. - The transition period for the second phase of solvency regulations has been extended to the end of 2025, prompting insurance companies to adjust their capital structures within the year [6]. - The current market environment, characterized by declining interest rates, provides favorable conditions for insurance companies to issue perpetual bonds at lower costs [7]. Group 3: Implications for Insurance Capital - Issuing perpetual bonds not only strengthens core solvency but also enhances insurance companies' ability to invest in the capital market [8]. - There is a positive correlation between solvency ratios and the allocation of equity assets, with a 50 percentage point increase in solvency ratio allowing for a 2% to 3% increase in equity asset allocation [9]. - The long-term nature of perpetual bonds aligns well with the long-term investment needs of insurance capital, effectively mitigating maturity mismatch risks [10].